| 2007.10.29 |
Our bivalent recombinant HPV vaccine (HPV 16/18) passed the verification check by the National Institute for the Control of Pharmaceutical and Biological Products, and obtained on Oct. 29, 2007 a report showing the testing results. |
| 2007.7.26 |
E coli. expressed recombinant HEV vaccine get the license of phase III clinical trial |
| 2007.7.10 |
The application and registration of E coli. expressed bivalent recombinant HPV vaccine (HPV 16/18) is launched |
| 2007.6.29 |
The therapy of Avian influenza virus(AIV) infection achieved great breakthrough in Fujian province |
| 2007.6.3 |
The application of patents “Truncated HPV 6 L1 protein” and “Truncated HPV 11 L1 protein” are accepted by China Patent & Trademark Office |
| 2007.4.29 |
The application of patents “Truncated HPV 16 L1 protein” and “Truncated HPV 18 L1 protein” are accepted by China Patent & Trademark Office |
| 2007.4.17 |
Our patent “New HEV peptide and method” is granted by the United States, the patent number is “7204989 B1” |
| 2007.3.25 |
Hepatitis E patients become 8 times more than ten years before in Hongkong |
| 2006.12.6 |
Hepatitis E existed and prevailed for at least 60 years in South China |
| 2006.11.1 |
“Recombinant Hepatitis E vaccine” is granted for the National Torch Planning Project |
| 2006.7.26 |
The project “YST research center and industrialization platform” is funded by Xiamen Grand Industrial Scientific Technology Plan |
| 2006.6.8 |
“Hepatitis E” originated from swine |
| 2006.12.22 |
YST-XiamenUniversityJointBio-pharmacyR&DCenter is invested by the government and setup the National Institute of Diagnostics and Vaccine Development in infectious diseases(NIDVD) |
| 2005.11.14 |
Project “HEV vaccine phase II/III clinical trial” is listed in “National small and medium scientific technological enterprises technology innovation funding” |
| 2005.9.20 |
Project “the immunization strategy of recombinant HEV vaccine” is listed in “the International Scientific Technological Cooperation Giant Projects” funded by the Ministry of Science and Technology of China |
| 2005.4.6 |
Our patent “New HEV peptide and method” is granted by China, the patent number is “ZL 00813582.7” |
| 2005.3.1 |
The first recombinant HEV vaccine in the world developed by GSK launched phase II clinical trial |
| 2005.1.25 |
Many “homeless” hepatitis are Hepatitis E |
| 2005.1.9 |
The first genetic Hepatitis E virus vaccine developed by China started up its phase I clinical trial |
| 2005.1.4 |
The recombinant Hepatitis E virus vaccine developed by YST and XiamenUniversity get the phase I /II clinical trial license |
| 2004.2.13 |
Hepatitis E diagnosis regents family has new member |
| 2002.8.1 |
Japan government screened for HEV in blood of swine
|
